Earlier research showed that primary care clinicians using AI-ECG tools identified more unknown cases of a weak heart pump, also called low ejection fraction, than without AI. New study findings published in Mayo Clinic Proceedings: Digital Health suggest that this type of screening is also cost-effective in the long term, especially in outpatient settings.
Biotech Stocks Well-PositionedFor The Fourth Quarter • Prudent Biotech
Biotechs are relatively better positioned in this fourth quarter compared to the broader market. The path of interest rates is clearer for 2022 and the